Log in to search using one of your social media accounts:


Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV ‐positive and HIV‐negative women in Rwanda

ConclusionsThe currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high‐risk patients.
Source: HIV Medicine - Category: Infectious Diseases Authors: Tags: Original Research Source Type: research

Related Links:

More News: African Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Cytology | Genital Warts | Gonorrhoea | Hepatitis | Hepatitis B | Hepatitis Vaccine | HPV Testing | Human Papillomavirus (HPV) | Infectious Diseases | Rwanda Health | Teaching | Teaching Hospitals | Trichomonas | Universities & Medical Training | Vaccines | Women